BR2 Pep-LNP is a state-of-the-art peptide-functionalized lipid nanoparticle (LNP), designed for efficient targeted delivery of therapeutic cargoes such as siRNA, mRNA, DNA, small molecule drugs, and RNA-guided gene editing systems. Engineered with the BR2 peptide, which interacts with specific receptors on the surface of target cells to facilitate precise localization and entry of the drug or nanocarrier into the target cell, particularly enhancing targeting efficiency in tumor therapy or gene therapy, this LNP offers enhanced specificity. Our LNP is prepared using Targeting Module and a variety of optional lipid formulations including DLin-MC3-DMA, LP-01, ALC-0315, SM102, and others. These formulations are carefully selected to ensure the LNP has uniform particle size, high encapsulation efficiency, stability, and targeted delivery. Applications of BR2 Pep-LNP include targeted cancer therapy, developing receptor-specific imaging agents, enhancing the delivery of anti-cancer drugs or gene editing tools to tumors, and studying receptor-mediated endocytosis and drug delivery mechanisms in various disease models. Please note that this product is intended for research purposes only.
Inquiry
SPECIFIC INQUIRY
Clear AllInquiry
For Research Use Only. Not for Diagnostic or Treatment Applications.